Quantitatively relating brain endothelial cell–cell junction phenotype to global and local barrier properties under varied culture conditions via the Junction Analyzer Program by Gray, Kelsey M. et al.
Gray et al. Fluids Barriers CNS           (2020) 17:16  
https://doi.org/10.1186/s12987-020-0177-y
RESEARCH
Quantitatively relating brain endothelial 
cell–cell junction phenotype to global and local 
barrier properties under varied culture 
conditions via the Junction Analyzer Program
Kelsey M. Gray1, Jae W. Jung1, Collin T. Inglut1, Huang‑Chiao Huang1,4 and Kimberly M. Stroka1,2,3,4* 
Abstract 
Background: The endothelial cell–cell junctions of the blood–brain barrier (BBB) play a pivotal role in the barrier’s 
function. Altered cell–cell junctions can lead to barrier dysfunction and have been implicated in several diseases. 
Despite this, the driving forces regulating junctional protein presentation remain relatively understudied, largely due 
to the lack of efficient techniques to quantify their presentation at sites of cell–cell adhesion. Here, we used our novel 
Junction Analyzer Program (JAnaP) to quantify junction phenotype (i.e., continuous, punctate, or perpendicular) in 
response to various substrate compositions, cell culture times, and cAMP treatments in human brain microvascular 
endothelial cells (HBMECs). We then quantitatively correlated junction presentation with barrier permeability on both 
a “global” and “local” scale.
Methods: We cultured HBMECs on collagen I, fibronectin, collagen IV, laminin, fibronectin/collagen IV/laminin, or 
hyaluronic acid/gelatin for 2, 4, and 7 days with varying cAMP treatment schedules. Images of immunostained ZO‑1, 
VE‑cadherin, and claudin‑5 were analyzed using the JAnaP to calculate the percent of the cell perimeter presenting 
continuous, punctate, or perpendicular junctions. Transwell permeability assays and resistance measurements were 
used to measure bulk (“global”) barrier properties, and a “local” permeability assay was used to correlate junction pres‑
entation proximal to permeable monolayer regions.
Results: Substrate composition was found to play little role in junction presentation, while cAMP supplements 
significantly increased the continuous junction architecture. Increased culture time required increased cAMP treat‑
ment time to reach similar ZO‑1 and VE‑cadherin coverage observed with shorter culture, though longer cultures 
were required for claudin‑5 presentation. Prolonged cAMP treatment (6 days) disrupted junction integrity for all three 
junction proteins. Transwell permeability and TEER assays showed no correlation with junction phenotype, but a local 
permeability assay revealed a correlation between the number of discontinuous and no junction regions with barrier 
penetration.
Conclusions: These results suggest that cAMP signaling influences HBMEC junction architecture more than matrix 
composition. Our studies emphasized the need for local barrier measurement to mechanistically understand the role 
of junction phenotype and supported previous results that continuous junctions are indicative of a more mature/
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Introduction
Endothelial cell–cell junctions, especially within the 
blood–brain barrier (BBB), are extremely important 
for maintaining normal physiological processes. They 
regulate numerous cell functions (e.g., migration, 
proliferation) and paracellular transport across the 
barrier, such that decreased junctional protein is 
associated with dysregulated transport and leaky 
vasculature [1, 2]. Despite the numerous diseases 
associated with altered junctions, [3] the mechanisms 
regulating junctional proteins remain relatively 
understudied, largely due to the lack of efficient 
techniques to quantitatively assess their presentation 
at sites of cell–cell adhesion. Furthermore, the specific 
influence of different junction phenotypes on BBB 
properties remains elusive. We have recently developed 
the Junction Analyzer Program (JAnaP) to quantify the 
phenotypic junction presentation within the endothelium 
[4, 5]. Here, we used the JAnaP to study the influence 
of junction phenotype on human brain microvascular 
endothelial cell (HBMEC) barrier properties.
One difficulty in studying the BBB in  vitro is the 
challenge associated with recapitulating the in  vivo 
HBMEC properties [6], such as the overexpression of 
the tightly structured network of endothelial junctions. 
One technique to improve tight junction formation 
and barrier properties, evidenced by junction 
immunostaining, Transwell permeability studies, 
and transendothelial electrical resistance (TEER) 
measurements, is the co-culturing of endothelial 
cells (ECs) with neural cells (e.g., astrocytes) or their 
conditioned medium [7–12]. This not only improved 
BBB properties but also provided insights into the roles 
of biochemical and physical contacts of brain ECs with 
other cells present in the in  vivo microenvironment. 
Another biomimetic approach has been the use 
of different matrix proteins that (at least partially) 
recapitulate the in  vivo basement membrane or the 
brain microenvironment. The basement membrane 
is known to have an important role in maintaining 
vascular function [13]. As such, is it unsurprising that 
constituents of this matrix (i.e., fibronectin, collagen 
type IV, and laminin; or combinations of the three) 
are reported to elevate TEER values relative to type 
I collagen in porcine brain capillary ECs, [14] and 
promote adhesion and spreading of iPSC-derived 
brain ECs [15]. Additionally, hyaluronic acid is a 
primary component of the brain microenvironment, 
[16] and has been shown to induce tube formation 
in a mouse-derived brain capillary EC line [17]. A 
mixture of hyaluronic acid and gelatin is reported to 
improve cell spreading of endothelial progenitor cells 
and human umbilical vein ECs (HUVECs) [18] and 
has been used for in  vitro models of the BBB [5, 19]. 
Another approach towards improving the brain EC 
phenotype is the activation of cyclic 3′-5′-adenosine 
monophosphate (cAMP)-dependent protein kinase 
(PKA) via cAMP, dexamethasone, or hydrocortisone, 
which is linked with improved barrier function 
[10, 20–23]. Specifically, we and others have shown 
that 8-(4-chlorophenylthio) adenosine-3′,5′-cyclic 
monophosphate sodium salt (CPT-cAMP) and 
4-(3-butoxy-4-methoxybenzyl) imidazolidin-2-one 
(RO-20-1724) decrease permeability and increase tight 
junctions in various EC types [4, 24–27]. Furthermore, 
barrier confluency and maturity are also reported to 
influence junction presentation within the endothelium 
[28, 29].
Here, our goal was to probe the influence of junction 
phenotype on HBMEC barrier properties using the 
JAnaP. We first investigated different in  vitro factors 
to identify conditions driving altered states of junction 
presentation in HBMEC monolayers. Specifically, we 
studied the effects of substrate protein coating, culture 
time, and treatment with cAMP supplements. We then 
used those parameters to evaluate barrier permeability 




Primary HBMECs were purchased from Cell Systems 
(ACBRI 376) and cultured as previously described 
[5]. Briefly, cells were seeded into flasks coated with 
0.1% gelatin, and cells were cultured in RPMI-1640 
medium supplemented with 20% FBS, 1% Pen/Strep, 
2 mM l-glutamine (Thermo Fisher Scientific), 30 μg/ml 
endothelial cell growth supplement (ECGS) (Millipore 
Sigma), and 100  μg/ml heparin (Millipore Sigma) at 
37  °C, with 5% CO2 and 50% humidity. Cells arrived in 
our lab mycoplasma-free upon receipt from Cell Systems 
(according to the certificate of analysis), expanded, and 
used for experiments within passages 7–10. Cultures 
stable endothelial barrier. Understanding what conditions influence junction presentations, and how they, in turn, 
affect barrier integrity, could lead to the development of therapeutics for diseases associated with BBB dysfunction.
Keywords: Blood–brain barrier, cAMP, JAnaP, Permeability
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were tested after approximately 6  months and found 
to be mycoplasma-free using the MycoAlert PLUS 
Mycoplasma Detection Kit (Lonza, LT07-701).
Substrate Coating and Experimental Conditions
On Day 0, glass bottom 24-well plates (Greiner Bio-One, 
662892) were coated with 175 μl of one of the following: 
100  µg/ml collagen I (CN) (Sigma Aldrich, C3867), 
100  µg/ml fibronectin (FBN) (Sigma Aldrich, F2006), 
100  µg/ml collagen IV (CIV) (Sigma Aldrich, C6745), 
100  µg/ml fibronectin + 100  µg/ml collagen IV + 2  µg/
cm2 laminin (Fbn:CIV:L or F:C:L), or 0.4% thiol-modified 
hyaluronan: 0.4% thiol-modified gelatin (HA/Gtn) (ESI-
BIO, GS313) for 30  min at 37  °C, or 2  µg/cm2 laminin 
(LN) (Sigma Aldrich, L4544) for 60  min at 37  °C. All 
constituents were resuspended per the manufacturer’s 
instructions, then diluted to the respective concentration 
in Dulbecco’s Phosphate-Buffered Saline, 1× with 
calcium and magnesium (Corning, 21-030-CV) (PBS). 
After coating the surface, the excess solutions were 
removed, the wells were rinsed with 37  °C PBS, 500  µl 
of warm HBMEC medium was added to each well, and 
the plate was incubated at 37  °C until HBMEC seeding 
(approximately 20 min). Cells were seeded (5 × 104 cells/
cm2, 9.5 × 104 cells/well), then 500  µl of warm medium 
was additionally added to each well, and the cells were 
cultured for 2, 4, or 7  days. Samples were treated with 
medium containing cAMP supplements: 250 μM 8-CPT-
cAMP (Abcam, ab120424) and 17.5  μM RO-20-1724 
(Tocris Bioscience, 0415), for 1, 3, or 6  days, or control 
HBMEC medium. These supplements are routinely used 
in EC culture to improve junction localization and barrier 
properties [4, 30–33]. For all experiments, the medium 
was first changed the day after cell seeding, then again on 
Days 3, 4, and 6 for the respective culture lengths. On the 
final day of culture, cells were fixed as described below 
in “Immunostaining” section. Three biological replicates 
were performed for each experiment. A summary of 
each culture condition is presented as Figs. 2a, 3a and 4a, 
respectively.
Immunostaining
HBMECs were rinsed with 37 °C PBS and fixed with 1% 
formaldehyde in PBS (ThermoFisher Scientific, BP531) 
for 20  min. Note that all steps were performed under 
gentle rocking. Samples were washed three times, 5 min 
each, with room temperature PBS, then permeabilized 
for 5  min with 0.25% TritonX-100 (Sigma-Aldrich) in 
PBS. The wash steps were repeated then the samples 
were blocked for 1 h at room temperature with 2% goat 
serum (Abcam) in PBS. Primary antibodies against ZO-1 
(rabbit polyclonal IgG, ThermoFisher Scientific, 61-7300, 
1:500) and VE-cadherin (mouse monoclonal IgG, Santa 
Cruz, sc-9989, 1:50) in 2% goat serum in PBS were added 
to the cells overnight at 4  °C. The next day, the wash 
and blocking steps were repeated. Secondary antibodies 
goat anti-rabbit Alexa Fluor 488 (Abcam, ab150077, 
1:100) or goat anti-rabbit Alexa Fluor 568 (ThermoFisher 
Scientific, A-11011), and/or goat anti-mouse Alexa 
Fluor 568 (ThermoFisher Scientific, A-11004, 1:100), 
and Hoechst (ThermoFisher Scientific, H3570, 1:2500 or 
4 μg/ml), were then added to the sample in PBS for 1 h at 
room temperature. The wash steps were again repeated 
prior to imaging. For claudin-5 staining (rabbit polyclonal 
IgG, Abcam, ab15106, 1:200), cells were instead fixed 
with 100% ice cold methanol (Sigma Aldrich) for 10 min 
and blocked with 2% goat serum in PBS containing 0.3% 
TritonX-100 for 1 h at room temperature.
Junction analysis
Junction presentation was quantified using the Junction 
Analyzer Program (JAnaP) [4], available for download 
at https ://githu b.com/Strok aLab/JAnaP . A simplified 
workflow of the JAnaP is presented in Fig.  1. Briefly, 
cells whose perimeter was completely visible within each 
image were traced via “waypointing”. For ZO-1 and VE-
cadherin quantification, waypointing was performed on 
the images of ZO-1 (captured in the green fluorescent 
channel, A488), and the waypoints were projected onto 
the images of VE-cadherin (captured in the red fluores-
cent channel, A568), as previously described in [5]. For 
claudin-5 quantification, the cells were traced using the 
red fluorescent channel (i.e., VE-cadherin immunostain-
ing) and the waypoints were projected onto the green 
fluorescent channel (i.e. claudin-5 immunostaining), 
as the cell-edge was more visible in the images of VE-
cadherin versus claudin. Note that the images reflect 
pseudo-color imaging. Threshold values of 15, 5, and 5, 
were applied to isolate the ZO-1, VE-cadherin, and clau-
din-5 junctions, respectively. Note that instructions on 
how to identify threshold values is described in the sup-
plement of [4] and in the JAnaP User-Guide available 
using the link above. In short, different threshold values 
were manually investigated for several cells representing 
the range of brightness throughout the sample images to 
identify a threshold value that appropriately isolates the 
junction pieces for that protein. The cell morphological 
parameters (e.g., area, solidity, circularity) were then cal-
culated, as well as the percent of the cell edge presenting 
continuous, punctate, or perpendicular junction. Junc-
tion phenotypes were classified based on the length of 
the junction piece that coincides with the cell path (> 15 
pixels for continuous junction) and the relative aspect 
ratio with respect to the cell path (> 1.2 for perpendicular 
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junction, otherwise punctate), which serve as constant 
parameters when using the JAnaP. Note that discontinu-
ous junctions refer to the sum of the punctate and per-
pendicular junction results.
Transwell permeability assay
For the Transwell permeability assay, HBMECs were 
seeded (5 × 104 cells/cm2, 1.6 × 104 cells/well) into 
Transwell inserts (Falcon, 24 well format, 1.0  µm pore 
size) that had been coated with 100  µg/ml FBN for 
30 min at 37 °C. The next day, the medium was changed 
to control medium or cAMP-medium. On the following 
day, solutions of 1 mg/ml FITC-Dextran (70 kDa, Sigma-
Aldrich) were prepared in the respective medium 
formulations. Each Transwell was moved to a new well 
containing 800  µl of fresh medium and the top well 
was replaced with 400  µl of the dextran-medium. After 
30  min at 37  °C, the medium in the bottom well was 
collected, and the fluorescence was measured using a 
BioTek Synergy Neo2 plate reader (Excitation/Emission: 
492/518  nm, Gain: 65). A standard curve was used to 
calculate the mass of dextran within the sample and the 
Fig. 1 JAnaP workflow. a Example cell of interest within a monolayer immunostained for ZO‑1. b Isolated cell junctions after the filtering and 
threshold value has been applied. c Example cells depicting solidity (orange) and circularity (gray) calculations, where A and P are the cell area and 
perimeter (white outline), and Aconvex is the convex area (yellow outline). d Criteria for junction categorization to differentiate between continuous 
(cont., blue), punctate (punct., magenta), and perpendicular (perp., light blue) junctions. e–f Categorized junctions for the cell of interest, where (e) 
also depicts the perimeter of the cell (thin white line) and a cropped image of the dotted white region to improve visibility of the junctions (scale 
bar = 20 μm)
Page 5 of 20Gray et al. Fluids Barriers CNS           (2020) 17:16  
Fig. 2 Immunofluorescence images and junction phenotype analysis for 2‑day culture. a Schematic representing treatment schedule for 2‑day 
experiment. b HBMECs on 6 substrate coatings, cultured for 2 days with and without cAMP treatment, stained for ZO‑1 (green), VE‑cadherin 
(red), and DNA (blue). (scale bar = 20 μm) Edge presentation of continuous (c, f), punctate (d, g), and perpendicular (e, h) junctions for ZO‑1 and 
VE‑cadherin, respectively. 72 ≤ N ≤ 125, where N is the number of cells. The Kruskal–Wallis test with a Dunn’s multiple comparison test was used to 
calculate significant differences, where *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. See Additional file 1: Table S2 for statistical comparison 
between each protein coating
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apparent permeability coefficient (P_app) was calculated 
as previously described by Tominaga et al., [34]:
where, V is the volume of the abluminal chamber, A is the 
surface area of the membrane,  [Cabluminal] is the measured 
abluminal dextran concentration at time, t, and  [Cluminal] 
is the initial luminal dextran concentration added. 
The inserts were then fixed and stained as described in 
the “Immunostaining” section above. For imaging, the 
membranes were removed from the inserts using an 
X-acto knife and sandwiched between two coverslips, 
luminal-side down. Three biological replicates were 
performed for this experiment.
Local (XPerT) permeability assay
To visualize areas of monolayer leakiness, and to cor-
relate them with junction phenotype, we adapted the 
XPerT permeability assay developed by Dubrovskyi 





et al. [35]. Here, however, FBN was biotinylated (B-FBN) 
using EZ-Link NHS-LC-LC-Biotin (ThermoFisher Sci-
entific, 21343) according to the manufacturer’s instruc-
tions. B-FBN was then adsorbed onto glass bottom 
24-well plates overnight at 4 °C. Excess protein was then 
removed, the wells were rinsed with PBS, and 500 µl of 
warm HBMEC medium was added to each well. The plate 
was incubated at 37  °C until HBMEC seeding (approxi-
mately 20  min). After the cells were seeded (5 × 104 
cells/cm2, 9.5 × 104 cells/well), 500  µl of warm medium 
was additionally added to each well, and the cells were 
cultured per the 2-day experiment in Fig.  2a. Immedi-
ately before fixing, samples were treated with 50  µg/ml 
FITC-avidin (ThermoFisher Scientific, A821) for 3  min 
to enable FITC-avidin binding to the underlying b-FBN 
at permeable sites of the monolayer. The samples were 
then fixed and stained for ZO-1 and VE-cadherin per the 
“Immunostaining” section above. Three biological repli-
cates were performed for each junction protein.
Fig. 3 Immunofluorescence images and junction phenotype analysis for 4‑day culture. a Schematic representing treatment schedule for 4‑day 
experiment. b HBMECs on Fbn, cultured for 4 days with 0, 1, or 3 days of cAMP treatment, stained for ZO‑1 (green), VE‑cadherin (red), and DNA 
(blue). (scale bar = 20 μm) Edge presentation of continuous, punctate, and perpendicular junctions for (c) ZO‑1 and (d) VE‑cadherin. 87 ≤ N ≤ 145, 
where N is the number of cells. The Kruskal–Wallis test with a Dunn’s multiple comparison test was used to calculate significant differences, where 
ns = p > 0.05, ***p < 0.001, and ****p < 0.0001
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Local permeability analysis
To analyze the results of the local permeability assay, two 
primary steps were performed. An example monolayer 
image is presented in Additional file 1: Figures S1 and S2 
to depict each step. First, image processing of the green-
channel images of the bound FITC-avidin was performed 
in ImageJ. To do this, every image was converted to 8-bit 
and a threshold intensity value of 240 was applied to 
create a binary image showing the presence or absence 
of a permeated region (PR). The second step was to 
process the red-channel junctional protein images 
using the JAnaP. This analysis differed from single cell 
analysis using the JAnaP, since every single cell border 
was waypointed, regardless of whether the entire cell 
was present in the image. The JAnaP-associated Jupyter 
Notebook [4] was then used to generate several images of 
the categorized junctions, in some cases, overlaid them 
onto the PR threshold images. For the quantification of 
this assay, several parameters were studied, as outlined 
below.
PR categorization
PRs were categorized as Uni, Bi, Tri, Quad, or Multi, 
depending on the number of cells the PR was associated 
with (1, 2, 3, 4, 5+, respectively) (Additional file 1: Figure 
S1). To quantify PR area, the Analyze Particles function 
in ImageJ was used on the PR threshold images. Images 
showing the cell edges on top of the PRs were used to 
manually identify the number of cells that each PR was 
adjacent to. Five images from each of the 3 trials were 
measured, and the average count of each PR category per 
image was calculated. The PR area measurements were 
averaged over all PRs within the respective category.
Fig. 4 Immunofluorescence images and junction phenotype analysis for 7‑day culture. a Schematic representing treatment schedule for 7‑day 
experiment. b HBMECs on Fbn, cultured for 7 days 0, 1, 3, or 6 days of cAMP treatment, stained for ZO‑1 (green), VE‑cadherin (red), and DNA (blue). 
(scale bar = 20 μm) Edge presentation of continuous, punctate, and perpendicular junctions for c ZO‑1 and d VE‑cadherin. 74 ≤ N ≤ 115, where N is 
the number of cells. The Kruskal–Wallis test with a Dunn’s multiple comparison test was used to calculate significant differences, where ns = p > 0.05, 
*p < 0.05, **p < 0.01, and ****p < 0.0001
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Junction analysis along PR length
To calculate the percent and count of junctions along the 
cell perimeters coinciding with PRs, images depicting the 
JAnaP-analyzed junctions overlaid onto the threshold 
images were used (Additional file  1: Figure S1). These 
overlaid images were manually traced in ImageJ using 
the segmented line tool. Importantly, only PRs greater 
than 400  pixels2 were included in this analysis. For 
each PR, the length of the cell path(s) overlapping the 
PR was manually traced to calculate the PR length. 
Then, the number and length of each junction type was 
subsequently summed. The difference was taken to be the 
length of the no junction regions. The summed length of 
each junction type divided by the PR length was taken 
to be the % Junction Along the PR Path. Three images 
from each of the 3 trials were measured, with the values 
calculated on a per PR basis.
Co‑localization analysis
For the co-localization analysis, the JAnaP-associated 
Jupyter Notebook was used to generate junction-
categorized images that presented all the junctions 
for each category within a given image, on a black 
background without the cell path (Additional file  1: 
Figure S2). These images were uploaded into ImageJ, 
converted to 8-bit, and a threshold was applied to isolate 
the junctions. A selection was then created to measure 
the total area of each junction type present within the 
image (A_total). Next, the PR threshold images were 
again uploaded into ImageJ. A selection was created 
to isolate the PRs and was used as a mask applied to 
each junction image. The junctions present outside of 
the masked PR region were removed, leaving only the 
junction pieces corresponding to the PRs remaining. 
Another selection was created to measure the area of 
each junction type that corresponded with PRs in the 
image (A_PR). The % Co-localization was taken as (A_
PR/A_total)*100 for each junction type.
Microscopy
All samples were imaged using a 60× oil objective on 
an inverted IX83 Olympus microscope and Olympus 
cellSens Software. For fixed-cell epifluorescence 
microscopy, images were simultaneously collected 
using the red, green, and blue filters. Images within the 
manuscript have been enhanced via ImageJ for improved 
visualization.
Statistical analysis
All statistical analysis and graph generation was 
performed using GraphPad Prism 8. For each data set, a 
D’Agostino-Pearson normality test was used to identity 
the normality of the data. If the data was normal, a one-
way ANOVA with a Tukey’s multiple comparison post 
hoc test was performed. More frequently, the data was 
non-normal, in which case the non-parametric Kruskal–
Wallis ANOVA with Dunn’s multiple comparison post 
hoc testing was performed instead. For instances where 
only two groups were compared, a Mann–Whitney 
test was used. A linear regression was used to compare 
the junction presentation with global permeability. No 
statistical significance (ns) was determined using p > 0.05, 
and statistical significance was indicated as *p ≤ 0.05, 
**p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001. Errors bars 
represent standard error of the mean. All data represents 
pooled values from three independent trials.
Results
cAMP supplements increase continuous ZO‑1 
and VE‑cadherin junctions, independently of substrate 
coating
Figure  2 presents HBMECs cultured for 2  days with 
and without cAMP supplements on six different matrix 
constituents. While almost no differences in cell area, 
solidity, or circularity were observed between each 
substrate coating (Additional file  1: Figure S3 and 
Table  S1), differences in junctional protein presentation 
were found. In general, CIV and LN induced lower 
junctional protein presentation compared to the other 
substrate coatings (Additional file  1: Table  S2). As 
expected, the addition of cAMP supplements significantly 
improved barrier architecture. Increases in continuous 
junction were observed with cAMP treatment for every 
condition for both ZO-1 and VE-cadherin (Fig. 2), with 
the greatest presentation observed on FBN (though, 
F:C:L and HA:G induced similar coverage). For ZO-1, 
cAMP increased punctate junctions only on CN and 
CIV, and increased both punctate and perpendicular 
junctions only on LN. Discontinuous VE-Cadherin, on 
the other hand, was significantly influenced by cAMP 
supplements. Specifically, cAMP treatment decreased 
punctate VE-cadherin and increased perpendicular 
VE-cadherin for nearly every condition except HA:Gtn 
in which perpendicular junctions remained unchanged. 
Note that the total junction coverage (i.e. sum of 
continuous, punctate, and perpendicular junctions) 
for the conditions of this and following experiments is 
presented in Additional file 1: Figure S4.
Extending cell culture requires increased cAMP treatment 
for similar junction coverage
We next investigated the effects of extending cell culture 
and cAMP treatment time to probe the ability of these 
parameters to further increase junction coverage. Since 
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we observed minimal differences between substrate 
protein coatings, here we focused our results on FBN. 
The immunofluorescence images, cell morphology, 
and junction presentation results on all other substrate 
coatings can be found in Additional file 1: Figures S5–S10 
and Tables S3–S6.
First, we studied the effects of extending the time in cell 
culture to 4 days. Figure 3 presents HBMECs cultured for 
this length of time with 0, 1, or 3 days of cAMP supple-
ment treatment. No changes in cell circularity or solidity 
were observed regardless of condition or treatment, and 
generally insignificant changes in cell area were observed, 
except on CIV and HA:Gtn where 1d cAMP generated 
led to smaller cell areas than the 3d treatment group (and 
1d cAMP in the case of HA:Gtn) (Additional file 1: Figure 
S6). Interestingly, though, cells were smaller in area after 
4 days of cultures compared to cells cultured for 2 days, 
except for 4D/3d cAMP groups where increased area 
was observed. Increased cAMP treatment increased both 
continuous and perpendicular ZO-1 and VE-cadherin 
(Fig.  3, Additional file  1: Figure S7, and Table  S4). The 
greatest continuous junction presentation was observed 
with 3d cAMP, where approximately 38% and 61% of 
the cell edge was covered for ZO-1 and VE-cadherin, 
respectively. These coverage values were similar to those 
observed in HBMECs cultured for 2 days with 1d cAMP, 
suggesting increased culture time required increased 
cAMP treatment to reach comparable junction presen-
tation. Punctate junctions, on the other hand, displayed 
different responses for ZO-1 and VE-cadherin. While no 
change in punctate ZO-1 was observed, punctate VE-
cadherin decreased with increased cAMP treatment.
Next, we studied the effects of extending cell cul-
ture to 7  days with 0d, 1d, 3d, or 6d cAMP treatment 
(Fig.  4 and Additional file  1: Figure S8). Again, cell 
circularity and solidity generally remained consistent 
regardless of cAMP treatment time, except on F:C:L, 
where increased cAMP treatment led to more solid 
and circular cells (Additional file 1: Figure S9). On the 
other hand, cells with the largest cell area were mostly 
observed with 6d cAMP. Notably, the cell area with 
7-day culture was comparable to the size of cells cul-
tured for 2  days, versus 4-day culture where smaller 
cells were observed. Continuous ZO-1 increased with 
increased cAMP treatment up to 3d, while continuous 
VE-cadherin increased with 1d of cAMP treatment and 
remained at the same level with 3d cAMP treatment 
(Fig.  4, Additional file  1: Figure S10, and Additional 
file  1: Table  T6). For both junction proteins, however, 
6d of cAMP treatment led to a significant decrease in 
continuous junction presentation, to values compa-
rable to that at 0d treatment. While no change in per-
pendicular junctions was observed, punctate ZO-1 
increased with 1d cAMP treatment, and punctate VE-
cadherin decreased with increased cAMP treatment up 
to 3d, then spiked up with 6d cAMP treatment. Cumu-
latively, the greatest total protein coverage observed 
during 7-day culture on FBN was with 3d cAMP treat-
ment, with approximately 54% of the cell edge covered 
by ZO-1 and 76% by VE-cadherin (Additional file  1: 
Figure S4). These values were comparable to the total 
coverage observed during 4-day culture with 3d cAMP 
treatment, and 2-day culture with 1d cAMP treatment. 
This suggests that increased cAMP treatment is needed 
to maintain ZO-1 and to a lesser extent, VE-cadherin, 
with increased culture time. Importantly, there seems 
to be a limit to this trend since a decrease in continuous 
junctions (and an increase in punctate VE-cadherin) 
was observed with 6d cAMP treatment. Furthermore, 
these studies suggest that FBN may be a suitable matrix 
for HBMEC culture to induce varying degrees of ZO-1 
and VE-cadherin coverage by varying cAMP treatment.
Increased cell culture time increases continuous claudin‑5 
junctions
Since tight junctions are known to assemble after adhe-
rens junctions, [36] we next investigated the effects of 
increased cell culture and cAMP treatment time on the 
phenotypic presentation of tight junction protein clau-
din-5 (Fig.  5). First, we cultured HBMECs for 4  days 
on FBN coating with 0d, 1d, or 3d cAMP treatment. 
We observed increased edge-localization of claudin 
with cAMP treatment, in the form of continuous and 
perpendicular junctions, independent of cAMP treat-
ment time, with no change in punctate junction pres-
entation (Fig. 5a, c). Next, we extended the culture time 
to 7  days, and observed minimal claudin presentation 
with 6d cAMP treatment, in line with our observations 
for ZO-1 and VE-cadherin (Fig. 5b, d). Maximal contin-
uous claudin was found to be approximately 35% with 
1d cAMP, higher than the approximate 30% observed 
with 1d cAMP treatment during 4-day culture. Punc-
tate claudin, however, was unchanged with cAMP 
treatment and was presented at comparable levels to 
those found during 4-day culture. With cAMP treat-
ment, perpendicular claudin was found at similar lev-
els between 4-day and 7-day culture, though 6d cAMP 
treatment significantly decreased presentation to the 
approximate levels of 4-day culture with 0d cAMP.
Transwell permeability (and TEER) assays are insufficient 
for correlative assessment of junction phenotype 
and barrier properties
Typically, continuous, linear adherens junctions are 
thought to be indicative of stable, mature EC barriers, 
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Fig. 5 Immunofluorescence images and junction phenotype analysis for claudin‑5. HBMECs on Fbn, cultured for a 4‑days and b 7‑days, with 0, 1, 3, 
or 6 days of cAMP treatment, stained for claudin‑5 (green), VE‑cadherin (red), and DNA (blue) (scale bar = 20 μm). Edge presentation of continuous, 
punctate, and perpendicular junctions for claudin‑5 for c 4‑day (19 ≤ N ≤ 47) and d 7‑day culture (21 ≤ N ≤ 52), where N is the number of cells. The 
Kruskal–Wallis test with a Dunn’s multiple comparison test was used to calculate significant differences, where ns = p > 0.05, *p < 0.05, **p < 0.01, 
***p < 0.001, and ****p < 0.0001
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while immature junctions are presented as punctate or 
perpendicular regions of protein [28]. As such, discon-
tinuous junctions are typically linked with decreased 
barrier function, such as increased permeability [37]. 
Since the conditions tested here generated varied pres-
entations of continuous and discontinuous junctions, 
we aimed to use these conditions to probe the influence 
of junction phenotype on barrier integrity using tradi-
tional measurement techniques (e.g., Transwell assays).
First, we performed a permeability assay by culturing 
HBMECs for 2  days on FBN-coated Transwell inserts, 
comparing the effects of 0d and 1d cAMP treatment on 
the permeability of 70  kDa FITC-dextran (Fig.  6). Since 
we observed a significant increase in junction coverage 
with 1d cAMP treatment in 2-day culture above, we 
expected to see decreased permeability with cAMP 
supplements. Indeed, the apparent permeability coef-
ficient (P_app) decreased with 1d cAMP (Fig.  6a). To 
correlate these permeability values with junction pres-
entation, the inserts were imaged and analyzed using the 
JAnaP (Fig. 6b, c), and the P_app values for each sample 
were plotted against calculated junction coverage val-
ues (Fig.  6d, e). Surprisingly, no significant correlation 
was found between junction coverage and permeability, 
which could suggest that ZO-1 and VE-cadherin pheno-
type have only a limited influence on the global perme-
ability of the monolayer to this FITC-dextran molecule, 
if at all. This result is very unlikely given the plethora of 
Fig. 6 Transwell permeability assay. a Apparent permeability coefficient (P_app) of HBMECs cultured for 2 days with 0d or 1d cAMP treatment. 
N = 6, where N is the number of inserts measured over 3 trials. Inserts were analyzed using the JAnaP for ZO‑1 (b) and VE‑cadherin (c), and the 
correlation between junction coverage and P_app were evaluated (d, e). A linear regression rendered the slope of all relationships non‑significantly 
non‑zero. For (b, c), 232 ≤ N ≤ 244, where N is the number of cells, and for (d, e), N = 12, where N is the number of inserts pooled between the 0d 
and 1d cAMP conditions. The Mann–Whitney test was used to calculate significant differences for each parameter, where ns = p > 0.05, *p < 0.05, 
**p < 0.01, ***p < 0.001 and ****p < 0.0001
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literary evidence suggesting otherwise [38–42]. Impor-
tantly, however, many of these reports are qualitatively 
correlative between immunostaining and permeability 
measurement, and not a quantitative correlation between 
permeability and junction presentation. Based on our 
results above in Figs. 2 and 6a, we could draw a similar 
conclusion that increased continuous junctions is linked 
with decreased permeability. This conclusion, however, 
assumes that the junction presentation of the cells within 
the two different experimental setups is consistent. To 
probe the validity of this assumption, we investigated 
the shape and junction characteristics of cells cultured 
on Transwell inserts (Fig. 6, Additional file 1: Figure S11) 
to compare them against the results when cells were cul-
tured on glass bottom plates (Fig. 2, Additional file 1: Fig-
ure S3). On glass, 1d cAMP treatment led to a decrease 
in cell area from approximately 2000  μm2 to 1500  μm2. 
Cells cultured on the inserts, however, were approxi-
mately 1700  μm2 in area regardless of cAMP treatment 
(Additional file  1: Figure S11). In both cases, circularity 
and solidity were similar with and without cAMP. While 
cAMP treatment increased continuous junctions in both 
cases, the resultant increase in overall coverage of contin-
uous junctions was less on the inserts compared to glass. 
Specifically, continuous ZO-1 and VE-cadherin, respec-
tively reached approximately 20% and 51% on the inserts, 
compared to the approximate 32% and 66% coverage val-
ues observed on glass.
We also measured TEER to probe barrier integrity 
and correlate the results with JAnaP analysis to gain 
insight into barrier resistance as a function of junction 
phenotype (Additional file  1: Additional Method S1). 
The 4-day experiment (Fig. 3b) on FBN with 0d, 1d, and 
3d cAMP treatment was selected to provide increased 
variation of the total junction coverage, expecting 
increased TEER with increased cAMP treatment 
(Additional file  1: Figure S12). Surprisingly, changes in 
TEER with cAMP were only minor and non-significant. 
Similar to the results from the permeability study, no 
correlation between junction presentation and resistance 
measurements were observed. Again, both cell area and 
junction presentation differed on the Transwell inserts 
(Additional file  1: Figure S13) compared to culture on 
glass (Fig.  3 and Additional file  1: Figure S6) and did 
not respond to cAMP treatment in the same manner. 
While continuous ZO-1 on FBN-coated glass increased 
from approximately 10% with 0d cAMP, to 20% with 
1d cAMP, and further to 40% with 3d cAMP (Fig.  3), 
the presentation on FBN-coated inserts increased from 
approximately 20% with 0d cAMP to approximately 
35% with 1d and 3d cAMP (Additional file  1: Figure 
S13). Similarly, while continuous VE-cadherin increased 
from approximately 15% with 0d cAMP, to 45% with 1d 
cAMP, and further to 60% with 3d cAMP on FBN-coated 
glass, the presentation on FBN-coated inserts increased 
from approximately 50% with 0d cAMP treatment to 
approximately 58% with 1d and 3d cAMP. For both 
ZO-1 and VE-cadherin, this result suggests that without 
cAMP supplements, Transwell inserts promote enhanced 
continuous junction presentation compared to culture on 
glass.
Overall, this motivated the use of a more localized 
assay to understand the effects of junction phenotype on 
local barrier function. Specifically, the ability to correlate 
local junction presentation with local barrier properties 
in  situ was needed to mechanistically quantify junction 
phenotype in conjunction with permeability.
Local permeability assay reveals correlation 
between discontinuous junctions and barrier penetration
To circumvent the challenges faced in the Transwell per-
meability and TEER assays, we adapted the XPerT assay 
[35] to detect regions of local monolayer permeability 
in  situ. This technique enables visualization of barrier 
permeation via FITC-avidin-binding to biotinylated-
FBN (B-FBN), in parallel with junction immunostaining. 
Here, we used this assay in conjunction with the JAnaP 
to quantitatively study junction phenotype and site-spe-
cific barrier permeability. Figure  7 presents representa-
tive images of VE-cadherin (A–C) and ZO-1 (D–F) in 
HBMECs cultured for 2  days. Note that no change in 
cell area was observed between FBN and B-FBN sub-
strates, suggesting that the biotin label does not signifi-
cantly affect HBMEC adhesion or spreading to the matrix 
(Additional file 1: Figure S14A). As expected, significantly 
more FITC-avidin was found to penetrate the endothelial 
cell barrier under conditions with 0d cAMP as compared 
to 1d cAMP treatment (Additional file 1: Figure S14B).
To start, we characterized the permeated regions (PR) 
of the monolayers, since the number of cells correspond-
ing to PRs was not always consistent. We therefore cat-
egorized each PR based on the number of cells with 
which it was associated (i.e., Uni, Bi, Tri, Quad, or Multi). 
To quantify each of these instances, we averaged the 
number of times each category was present within each 
image (Fig.  8a). Note that these results were calculated 
using the monolayers immunostained for VE-cadherin, 
though similar results were observed when calculated for 
the ZO-1-stained images (Additional file 1: Figure S15). 
Bi-cellular PRs were the most consistent PR, with about 
16 PRs per image (Fig. 8a). Larger PRs such as Quad or 
Multi were much less common, occurring less than or 
equal to one time per image. Size analysis indicated that 
PR area significantly increased with each additional cell 
contact, such that Uni PRs were smallest and Multi PRs 
were much larger (Fig. 8b).
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Fig. 7 Local permeability assay. Immunofluorescence images of HBMECs cultured for 2 days on b‑FBN with 0d of 1d cAMP, treated with FITC‑avidin 
(green), then stained for VE‑cadherin (row A, red), ZO‑1 (row C, red), and DNA (blue). Rows B and C provide a zoomed‑in view of the region outlined 
in the white‑dotted box in the respective images (scale bar = 20 μm, applies to rows A and C)
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Next, we investigated the types of junctions present at 
the PRs. We found the regions of cell path overlapping 
PRs were dominated by no junction regions for both 
VE-cadherin and ZO-1, though punctate junctions were 
also increased for ZO-1 (Fig. 8c–f). This suggests that in 
regions where FITC-avidin penetrated the barrier, the cell 
edge was most commonly covered by regions of “no junc-
tion”, and also significantly covered by punctate ZO-1. To 
gauge how frequently each junction type corresponded 
with a PR, we calculated the co-localization percentage 
for each image. While co-localization was greater for 
punctate VE-cadherin versus continuous junctions, no 
difference in co-localization amongst ZO-1 junctions was 
observed (Fig. 9g, h). Interestingly, the co-localization for 
both VE-cadherin and ZO-1, ranging from about 18–44% 
for all junctions, suggests that while punctate junctions 
are more likely to associate with a PR, their presence 
does not necessarily indicate a permeable region of the 
monolayer.
We were then curious to see if the amount of any one 
junction type (or no junction region) would instead 
correlate with “how permeable” the permeable regions 
were. We measured the extent of permeability as the 
area of the PR and investigated the correlation between 
PR area and junction presentation (Fig.  9). Note that 
these graphs have excluded 2 very large Multi PRs that 
were likely affected by more than just the local junction 
presentation of these proteins. Since the percentage 
of no junction regions dominated the PR length for 
both VE-cadherin and ZO-1, the magnitudes of values 
on this line were greater than either continuous or 
discontinuous (Fig.  9a, b). For VE-cadherin, there was 
no statistically significant correlation between percent 
junction (of any type) and PR area (Additional file  1: 
Table  S7). For ZO-1, however, discontinuous junctions 
showed a significant correlation (p < 0.05,  R2 = 0.039). 
This was likely driven by punctate junctions (p < 0.05, 
 R2 = 0.044), since a significant correlation was found for 
punctate junctions but not perpendicular junctions. On 
the other hand, analysis of the junction counts showed 
significant trends for every condition. Since the junctions 
are inherently categorized by size (i.e., continuous are 
at least 15 pixels (or ~ 2.7  μm) long), looking at the 
number of junctions considers the smaller sizes of 
discontinuous junctions relative to continuous junctions, 
and that could be inadvertently skewing the percentage 
results. For both VE-cadherin and ZO-1, all junction 
types presented a significant correlation (p < 0.0001), 
with discontinuous and no junctions showing a greater 
positive correlation compared with continuous junctions 
(Fig.  9 and Additional file  1: Table  S7). Together this 
suggests that size of the PR, or how permeable the barrier 
is as permeable regions, is equally influenced by the 
presentation of discontinuous junction and no junction, 
with continuous junctions playing less of a role.
Discussion
While the influence of junction protein localization and 
presentation at the cell–cell borders of ECs on barrier 
properties has been previously investigated, these studies 
have been performed in a primarily qualitative manner 
and have lacked the quantification of junction phenotype. 
Development of the JAnaP has enabled the quantitative 
analysis of cell–cell junctions in situ, thereby permitting 
the study of junction phenotype on EC barrier properties 
in a calculated manner. Here, we varied cell culture 
parameters to understand their influence on junction 
presentation, and then used them to probe the effects on 
barrier permeability.
Despite the different properties of the six difference 
matrices studied here, [13, 43] use of different substrate 
coatings had almost no effect on cell shape factors and 
had the strongest influence on continuous (and in some 
cases, punctate) ZO-1 and VE-cadherin junctions. CN, 
Fbn, F:C:L, and HA/Gtn, all induced similar levels of 
total junction coverage, in line with previous reports for 
various brain EC types [14, 15, 44], while CIV and LN 
induced less junction localization in some cases. The 
result that LN induced a less optimal BBB phenotype was 
not surprising, since previous reports with iPSC-derived 
brain ECs reported the lowest TEER values and occludin 
expression on LN compared to other proteins, including 
several that were studied here [13]. That study also 
reported the greatest TEER values on FBN, supporting 
our result that, while marginal, FBN induced the greatest 
junction protein coverage [13]. Others have also reported 
the importance of FBN in brain endothelial cell culture 
to initiate and maintain a BBB phenotype. For example, 
Tilling et al. have suggested that FBN influences porcine 
brain capillary endothelial cell differentiation [45], and 
(See figure on next page.)
Fig. 8 Permeated region and junction presentation analysis. The average number of each PR type per image is presented in a while the average 
size of each PR type is presented in b. N = 15 for (a) where N is the number of images. 11 ≤ N ≤ 247 for (b) where N is the number of PRs. Percentage 
(c, d) and count (e, f) of ZO‑1 (left column) and VE‑cadherin (right column) junctions along the cell edges co‑localized with PRs. N = 105 for 
VE‑cadherin and 126 for ZO‑1, where N is the number of PRs. The co‑localization of ZO‑1 (g) and VE‑cadherin (h) with PRs. N = 9, where N is the 
number of images. The Kruskal–Wallis test with a Dunn’s multiple comparison test was used to calculate significant differences for a–f and a Mann–
Whitney test was used for (g, h), where ns = p > 0.05, *p < 0.05, **p < 0.01, and ****p < 0.0001
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others have reported high resistance values in these cells 
only in the presence of astrocyte- and pericyte-derived 
matrices, which were found to contain large amounts 
of FBN (relative to CIV) [46, 47]. Interestingly, while 
increased claudin expression was found on matrices 
with increased FBN, ZO-1 expression was consistent 
regardless of FBN or CIV composition, in line with our 
results for ZO-1 on these matrices at longer culture 
times. The addition of cAMP supplements was found 
to have the greatest effect in junction presentation, 
increasing continuous junctions in almost every case. 
This was not surprising given the significant evidence 
that these supplements improve the barrier phenotype 
in ECs [24, 25]. Of specific relevance, one study 
reported increased TEER and localization of ZO-1 
and VE-cadherin, showing a more linear morphology 
(assessed qualitatively) in HUVECs treated with the 
same concentrations of cAMP supplements for 1  day, 
supporting our results in this study [31]. Interestingly, 
increasing culture time in the presence of cAMP did not 
increase junction coverage for ZO-1 or VE-cadherin, 
and required longer cAMP treatment to reach similar 
presentation values observed in shorter experiments 
(FBN results presented in Additional file 1: Figure S16). 
This was surprising, since barrier maturity is thought 
to correlate with a more continuous, linear junction 
phenotype, but here required additional biochemical 
signaling. Furthermore, it seemed that time of culture 
prior to adding cAMP affected junction organization 
after cAMP was added. Future work should explore the 
time-dependent mechanisms driving cell–cell junction 
formation and maturation. Notably, a total culture time 
of 2-days or 7-days generally increased continuous and 
perpendicular junctions compared to 4-day experiments 
for both 0d and 1d cAMP treatment groups, suggesting 
total culture time does influence junction presentation 
but this effect seems to be mitigated with longer cAMP 
treatment. This could possibly involve cell contractility 
pathways, since cAMP reportedly inhibits Rho/ROCK 
signaling in endothelial cells, which blocks myosin light 
Fig. 9 Junction Presentation versus PR Area. The correlation between PR area and the percent (a, b) and count (C,D) each continuous (Cont.), 
discontinuous (Disc.), and no junction (No Junct.) regions at the cell edge that are co‑localized with a PR for ZO‑1 and VE‑cadherin. All results were 
fit using a linear regression. N = 105 for (a, c) and 124 (b, d), where N is the number of PRs. The Cont., No. Junct. Disc., Punctate, and Perp.  R2 values 
are as follows: 0.001, 0.019, 0.039, 0.044, and 2.11E−4 for (a), 0.008, 0.009, 0.007, 0.010, and 9.80E−5 for (b) 0.213, 0.662, 0.617, 0.510, and 0.546 for (c), 
0.143, 0.451, 0.493, 0.387, and 0.310 for (d). See Additional file 1: Table S4 for a summary of the statistical analysis for slope significance
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chain phosphorylation [48], leading to increased linear 
VE-cadherin formation [49], and presumably, decreased 
cell contractility. This contractility pathway may be 
downregulated during extended culture times, as the 
monolayer matures, and cells secrete new extracellular 
matrix. Then, addition of cAMP may have less of an 
effect because the Rho/ROCK pathway has already been 
downregulated. Future work could indeed explore this 
hypothesis.
For claudin-5, on the other hand, we did observe 
increased presentation with increased culture time, 
since no claudin was observed at 2 days and a maximal 
value was observed with 1d cAMP treatment during 
7-day culture. This effect of culture time was expected, 
since tight junctions form after adherens junctions, 
requiring adherens junction structure for tight junction 
organization [2]. This difference in response of claudin 
to cAMP treatment time compared to VE-cadherin 
and ZO-1 was interesting, and possibly indicates 
different mechanisms regulating tight and adherens 
junction proteins. The requirement for increased cAMP 
signaling with increased culture time for ZO-1 and 
VE-cadherin did reach a limit, however, since 6d cAMP 
treatment during 7-day culture led to a decrease in 
junction architecture. This supports reports by Perrot 
et  al., that prolonged activation of cAMP signaling can 
disrupt EC barriers [50]. Since cAMP is a regulator of 
gene expression, increases in its signaling can cause a 
delayed repression of Ras-related protein (R-Ras), which 
stabilizes VE-cadherin, thereby compromising junction 
stability and barrier integrity. Therefore, it is important 
to limit prolonged cAMP treatment and activation to 
maintain increased barrier function.
To correlate barrier properties with junction 
presentation, we performed Transwell permeability and 
TEER measurements. As expected, our permeability 
coefficient decreased with cAMP treatment, to a 
similar value reported for the B.end3 brain EC cell 
line in comparable conditions with 70  kDa Dextran 
(approximately 1E − 06  cm/s) [51]. The TEER 
measurements were on par with literature values, on 
the order of 10–30 Ω  cm2 for static monoculture of 
B.end3 cells, [51] primary rat brain ECs, [52] purified 
murine brain ECs, [53] as well as for HBMECs [32]. 
The resultant trends, however, were not expected, since 
no significant differences were observed with cAMP 
treatment. Furthermore, neither TEER nor permeability 
showed a correlation with junction coverage. While this 
was surprising, there are several reasons to explain this 
unexpected result. First, the HBMEC monolayer may 
not be homogenous throughout the entire insert. Any 
gaps or regions of heterogeneity could lead to increased 
permeability, significantly skewing the P_app result, 
or decreased resistance due to “shortcuts to current 
flow” [54], since these are “bulk” barrier measurements. 
Second, the observed permeability response may be due 
to use of FITC-Dextran as the permeability marker, since 
molecules with different properties (e.g., size, charge) 
can permeate the barrier differently [54]. Third, the cells 
could be behaving differently due to the experimental 
conditions of the Transwell assays compared to on the 
glass bottom plates. Our JAnaP results suggest that 
indeed, the HBMECs are different in size and changes in 
junction architecture in response to cAMP are different 
compared to the glass bottom conditions. Notably, 
without cAMP treatment, we found Transwell inserts 
to induce higher continuous junction presentation in 
comparison with glass. These different trends for cell 
area and junction presentation could be explained by 
differences in the assay (e.g., treatment with FITC-
Dextran, or cAMP supplements to both the apical and 
basal side), differences in the surface characteristics 
(e.g., charge, matrix coating efficiency), or possibly the 
different mechanical environments (i.e., stiff glass versus 
softer membrane, which we and other have previously 
shown to influence barrier integrity [4, 37, 55]). This 
could potentially explain the lack of correlation observed 
between junction phenotype and permeability, since 
one possibility is that the magnitude of change of each 
junction type did not vary enough to influence these 
measurements. This would mean that significantly 
more (or less) junction presentation would be required 
to alter the overall permeability or resistance of the 
barrier. Notably, continuous junction coverage alone 
fluctuated about 20–30% between cAMP treatments, 
suggesting that more extreme coverage values such as 
less than 10% or greater than 60% might be required 
to affect the output measurements. Other reports that 
qualitatively associated changes in junction phenotype 
and localization with barrier measurement often use 
treatments such as inflammatory cytokines (e.g., TNF-
α) which could be altering other cell features that 
drive the changes in TEER rather than just phenotypic 
changes in junction presentation [56, 57]. For example, 
TNF-α treatment has been shown to induce the 
formation of filopodia, membrane ruffles, actin stress 
fibers, and intercellular gaps in human umbilical vein 
ECs [58]. Often in literature, the immunofluorescent 
staining of cells is performed, the TEER or permeability 
measurement is performed separately, and the two results 
are then correlated to infer function. We have shown 
here that cells can respond differently in the different 
systems and as such, caution should be taken when 
comparing cellular responses in different environments. 
These results motivated the use of a local assay to 
measure site-specific permeability in a single system that 
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enables direct correlative measures. Since ECs can sense 
and respond to their microenvironment, EC phenotypes 
and barrier permeability are known to display spatial 
heterogeneity, further supporting the use of local studies 
to gain mechanistic insights into EC function [2, 59]. 
Furthermore, a local permeability assay would be more 
advantageous to use in complex microsystems where 
TEER or permeability measurements are not feasible. 
However, in some cases, global assays still provide 
valuable understanding, since the assessment of whole 
barrier function is important in, for example, in  vitro 
modeling for the study of drug delivery systems.
The local permeability studies showed that permeated 
regions were most affected by the number of punctate 
and no junction regions of coverage, which had a positive 
correlation with PR area. This result supports the generally 
accepted idea that continuous junctions are indicative of a 
more mature and stable barrier [60–62]. This study also 
implicates punctate (versus perpendicular) junctions in 
the regulation of monolayer permeability, though future 
investigation is needed to unveil the differences between 
these two discontinuous junction types. It is important 
to note that this assay is only measuring the permeability 
of FITC-avidin and as such, could return different results 
for the permeability of molecules of different sizes or 
charges; or for different cell types transmigrating across 
the barrier. Use of the JAnaP with other local permeability 
assays for different molecules [63] or live cell imaging 
for cell transmigration [5, 64–66] could, therefore, 
provide additional insights into the effects of junction 
phenotypes. This is especially of interest to further 
study the differences in function between punctate and 
perpendicular junctions. Also of note, is that these studies 
were performed in static culture, despite the evidence 
suggesting the significant influences of mechanical cues in 
EC function [55]. Therefore, performing these correlative 
local permeability and TEER (or impedance) studies in 
a system that enables the incorporation of biomimetic 
microenvironmental cues (e.g., shear stress [13], substrate 
stiffness [28]) to probe the interplay of these parameters 
on a local scale is an important future application.
Overall, this study highlights the capabilities of com-
bining junction phenotyping and assessment of barrier 
function for the mechanistic study of the BBB, and pos-
sibly other EC and epithelial barriers. Together, our data 
quantitatively suggest that increased continuous junction 
presentation is associated with a less permeable barrier, 
with increased gaps or discontinuous junctions indicating 
increased permeability. Our methods could provide valu-
able quantitative insights into time-dependent changes 
in junction architecture that occur in different biochemi-
cal or mechanical conditions. Understanding what con-
ditions influence junction presentations and how that 
affects barrier properties could lead to therapeutic devel-
opment for diseases associated with BBB dysfunction or 
delivery mechanisms capable of traversing healthy barrier 
systems.
Conclusion
In summary, we investigated the influence of cell culture 
parameters such as matrix protein coating, culture time, 
and cAMP treatment, and used the JAnaP to quantify 
their role in cell and junction morphology. While protein 
coating seemed to have only a modest effect on these 
parameters, cAMP treatment significantly increased 
continuous junction presentation. Total cell culture 
time did not increase junction presentation, but instead 
required increased cAMP treatment for protein coverage 
comparable to shorter culture time. No correlation 
between junction presentation and barrier permeability 
was found when comparing junction phenotype to 
Transwell-based TEER and permeability experiments, 
motivating the use of an assay that could instead capture 
cell-to-cell inhomogeneities rather than a “bulk” barrier 
measurement. A local permeability assay identified 
that barrier permeability most closely correlates with 
the number of gaps with no junction coverage, and 
by extension, the number of discontinuous junctions, 
present at the cell edge. Together this promotes the use 
of local measurement techniques to quantitatively study 
barrier function in conjunction with junction phenotype 
to investigate the mechanisms at play in functional and 
dysfunctional barrier systems.
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ated region; RO‑20‑1724: 4‑(3‑Butoxy‑4‑methoxybenzyl) imidazolidin‑2‑one; 
TEER: Transendothelial electrical resistance; VE‑cadherin: Vascular endothelial 
cadherin; ZO‑1: Zonula occludens 1.
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